发明名称 |
RADIOLABELED COMPOUND DIRECTABLE IN VIVO TO TARGET TISSUE AND USE THEREOF |
摘要 |
<p>Provided is a clinically usable radiolabeled compound which is precisely directable in vivo to a target tissue. The compound comprises either a first polypeptide or an analogue thereof and a second polypeptide bonded to the N terminal thereof. In the compound, the first polypeptide is a polypeptide that specifically combines with a protein which has appeared in the target tissue, and the second polypeptide includes an amino acid region which has a high affinity for radioactive metal nuclides and on which a radioactive metal nuclide having a high affinity for the amino acid region is held.</p> |
申请公布号 |
WO2011078250(A1) |
申请公布日期 |
2011.06.30 |
申请号 |
WO2010JP73189 |
申请日期 |
2010.12.22 |
申请人 |
RIKEN;WATANABE, YASUYOSHI;HASEGAWA, KOKI |
发明人 |
WATANABE, YASUYOSHI;HASEGAWA, KOKI |
分类号 |
C07K19/00;A61K51/00;A61P35/00;C07K14/47;C12N15/09;C12P21/02;C12Q1/04;G01T1/161 |
主分类号 |
C07K19/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|